Friday, 8 June 2018 EAU Update on Bladder Cancer (BCa18) Challenging your knowledge of the EAU Guidelines 8-9 June 2018, Munich, Germany Steering committee: F. Montorsi, H. Van Poppel and M. Wirth Scientific committee: A. Necchi, J. Palou, T. Powles and A. Stenzl 08.00-08.15 Introduction and format of the meeting 08.15-09.00 High risk non-muscle invasive bladder cancer: From guidelines to future approaches Chairs: A. Lopez Beltran, Lisbon (PT) S. Shariat, Vienna (AT) 08.15-08.30 EAU and ESMO Guidelines on Non-Muscle Invasive Bladder Cancer (NMIBC). What s new and what needs to be changed 08.30-08.40 WHO 2016 classification R. Montironi, Ancona (IT) 08.40-08.50 Immunotherapy in non-muscle invasive urothelial bladder cancer: Towards a new multidisciplinary paradigm? A. Kamat, Houston (US) 08.50-09.00 Discussion 09.00-12.30 Case discussion 1 (Interactive voting session) Faculty group 1: How to optimise TURBT? Speakers: P. Gontero, Turin (IT) F. Witjes, Nijmegen (NL) Faculty group 2: Bladder instillations: When and how? Speakers: P. Chlosta, Cracow (PL) Faculty group 3: Early cystectomy for NMIBC: Indications for patient selection Speakers: A. Kamat, Houston (US) M. Roupret, Paris (FR)
09.00-10.00 Faculty group 1 room 2 10.00-10.30 Coffee break 10.30-11.30 Faculty group 2 room 2 11.30-12.30 Faculty group 3 room 2 12.30-13.30 Lunch 13.30-14.00 Muscle invasive and advanced bladder cancer: Surgical and systemic approaches Chairs: M. Colombel, Lyon (FR) 13.30-13.45 EAU and ESMO Guidelines on Muscle Invasive Bladder Cancer (MIBC). What s new and what needs to be changed J. Bellmunt, Boston (US) 13.45-14.00 New drugs and therapeutic sequences in locally-advanced stages 14.00-17.30 Case discussion 2 (Interactive voting session) Faculty group 1: Neoadjuvant and adjuvant therapy: Current indications, trials, and patient selection Speakers: Faculty group 2: Technical aspects of open radical cystectomy Speakers: H. Van Poppel, Leuven (BE) Faculty group 3: Radical cystectomy: Indications and tricks for the robotic approach Speakers: M. Gallucci, Rome (IT) F. D Hont, Aalst (BE)
14.00 15.00 Faculty group 1 room 2 15.00 16.00 Faculty group 2 room 2 16.00 16.30 Coffee break 16.30 17.30 Faculty group 3 room 2 Saturday, 9 June 2018 08.00-09.00 What is new in bladder cancer classification and treatment? Chairs: J. Bellmunt, Boston (US) R. Montironi, Ancona (IT) M. Roupret, Paris (FR) 08.00-08.15 The shifting landscape of molecular classification: The impact of Genomics in clinical practice S. Lerner, Houston (US) 08.15-08.30 Immunotherapy for metastatic bladder cancer: PD-1/PD-L1 pathway and clinical implications 08.30-08.45 Unresectable tumours: Palliative management of Muscle Invasive Bladder Cancer (MIBC) and role of surgery postchemotherapy M. Brausi, Modena (IT) 08.45-09.00 Discussion 09.00-12.30 Case discussion 3 (Interactive voting session) Faculty group 1: Histological variants in bladder cancer: How to deal with them? Speakers: S. Lerner, Houston (US) S. Shariat, Vienna (AT)
Faculty group 2: Palliative cystectomy: Indications and patient selection Speakers: M. Ribal, Barcelona (ES) Faculty group 3: Management of metastatic bladder cancer Speakers: J. Bellmunt, Boston (US) 09.00-10.00 Faculty group 1 room 2 10.00-10.30 Coffee break 10.30-11.30 Faculty group 2 room 2 11.30-12.30 Faculty group 3 room 2 12.30 13.30 Lunch 13.30-13.45 Novel biomarkers and drug combinations for urothelial cancer 13.45-14.30 Postoperative management of surgical patients Chairs: P. Gontero, Turin (IT) A. Karl, Munich (DE) 13.45 14.00 Enhanced recovery after radical cystectomy (ERAS) and immunonutrition in bladder cancer patients J. Catto, Sheffield (GB) 14.00-14.15 Sexual and urinary rehabilitation after bladder cancer A. Briganti, Milan (IT) 14.15-14.30 Discussion 14.30-16.30 Case discussion 4 (Interactive voting session) Faculty group 1: Radical cystectomy: How to optimise peri and postoperative management and manage complications Speakers: J. Catto, Sheffield (GB) J. Kelly, London (GB)
Faculty group 2: Bladder sparing in Muscle Invasive Bladder Cancer (MIBC): Selection and optimal treatment Speakers: A. Choudhury, Manchester (GB) V. Fonteyne, Ghent (BE) 14.30 15.30 15.30 16.30 16.30 16.40 Close